{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:23:32Z","timestamp":1792607012495,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,9,12]],"date-time":"2010-09-12T00:00:00Z","timestamp":1284249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1038\/ni.1935","type":"journal-article","created":{"date-parts":[[2010,9,12]],"date-time":"2010-09-12T13:08:26Z","timestamp":1284296906000},"page":"897-904","source":"Crossref","is-referenced-by-count":1225,"title":["Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1\u03b2 in type 2 diabetes"],"prefix":"10.1038","volume":"11","author":[{"given":"Seth L","family":"Masters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoba L","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian M","family":"Tannahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona A","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Mullooly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C","family":"Coll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingston H G","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Hun","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Newsholme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Yodoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed C","family":"Lavelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A J","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,12]]},"reference":[{"key":"BFni1935_CR1","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn, S.E., Hull, R.L. & Utzschneider, K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840\u2013846 (2006).","journal-title":"Nature"},{"key":"BFni1935_CR2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/dmrr.1011","volume":"25","author":"OT Njajou","year":"2009","unstructured":"Njajou, O.T. et al. Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study. Diabetes Metab. Res. Rev. 25, 733\u2013739 (2009).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"BFni1935_CR3","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1126\/science.3086977","volume":"232","author":"K Bendtzen","year":"1986","unstructured":"Bendtzen, K. et al. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 232, 1545\u20131547 (1986).","journal-title":"Science"},{"key":"BFni1935_CR4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.2337\/diabetes.52.3.812","volume":"52","author":"J Spranger","year":"2003","unstructured":"Spranger, J. et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52, 812\u2013817 (2003).","journal-title":"Diabetes"},{"key":"BFni1935_CR5","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJMoa065213","volume":"356","author":"CM Larsen","year":"2007","unstructured":"Larsen, C.M. et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356, 1517\u20131526 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFni1935_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237\u2013241 (2006).","journal-title":"Nature"},{"key":"BFni1935_CR7","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.1156995","volume":"320","author":"C Dostert","year":"2008","unstructured":"Dostert, C. et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674\u2013677 (2008).","journal-title":"Science"},{"key":"BFni1935_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/ni.1631","volume":"9","author":"V Hornung","year":"2008","unstructured":"Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847\u2013856 (2008).","journal-title":"Nat. Immunol."},{"key":"BFni1935_CR9","first-page":"151","volume":"9","author":"A Clark","year":"1988","unstructured":"Clark, A. et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res. 9, 151\u2013159 (1988).","journal-title":"Diabetes Res."},{"key":"BFni1935_CR10","doi-asserted-by":"publisher","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","volume":"84","author":"GJ Cooper","year":"1987","unstructured":"Cooper, G.J. et al. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. USA 84, 8628\u20138632 (1987).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1935_CR11","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","volume":"84","author":"P Westermark","year":"1987","unstructured":"Westermark, P. et al. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc. Natl. Acad. Sci. USA 84, 3881\u20133885 (1987).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1935_CR12","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2337\/diabetes.53.6.1509","volume":"53","author":"AE Butler","year":"2004","unstructured":"Butler, A.E. et al. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes. Diabetes 53, 1509\u20131516 (2004).","journal-title":"Diabetes"},{"key":"BFni1935_CR13","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.1073\/pnas.93.14.7283","volume":"93","author":"J Janson","year":"1996","unstructured":"Janson, J. et al. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc. Natl. Acad. Sci. USA 93, 7283\u20137288 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1935_CR14","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1073\/pnas.93.8.3492","volume":"93","author":"CB Verchere","year":"1996","unstructured":"Verchere, C.B. et al. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc. Natl. Acad. Sci. USA 93, 3492\u20133496 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1935_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/BF00452067","volume":"29","author":"CF Howard Jr.","year":"1986","unstructured":"Howard, C.F. Jr. Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia 29, 301\u2013306 (1986).","journal-title":"Diabetologia"},{"key":"BFni1935_CR16","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/s001250100531","volume":"44","author":"S Seino","year":"2001","unstructured":"Seino, S. S20G mutation of the amylin gene is associated with type II diabetes in Japanese. Study Group of Comprehensive Analysis of Genetic Factors in Diabetes Mellitus. Diabetologia 44, 906\u2013909 (2001).","journal-title":"Diabetologia"},{"key":"BFni1935_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3109\/13506120108993820","volume":"8","author":"Z Ma","year":"2001","unstructured":"Ma, Z. et al. Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide. Amyloid 8, 242\u2013249 (2001).","journal-title":"Amyloid"},{"key":"BFni1935_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00125-008-1185-7","volume":"52","author":"J Udayasankar","year":"2009","unstructured":"Udayasankar, J. et al. Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets. Diabetologia 52, 145\u2013153 (2009).","journal-title":"Diabetologia"},{"key":"BFni1935_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/BF00400722","volume":"38","author":"P Westermark","year":"1995","unstructured":"Westermark, P., Eizirik, D.L., Pipeleers, D.G., Hellerstrom, C. & Andersson, A. Rapid deposition of amyloid in human islets transplanted into nude mice. Diabetologia 38, 543\u2013549 (1995).","journal-title":"Diabetologia"},{"key":"BFni1935_CR20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJMc0802893","volume":"359","author":"GT Westermark","year":"2008","unstructured":"Westermark, G.T., Westermark, P., Berne, C. & Korsgren, O. Widespread amyloid deposition in transplanted human pancreatic islets. N. Engl. J. Med. 359, 977\u2013979 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFni1935_CR21","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/368756a0","volume":"368","author":"A Lorenzo","year":"1994","unstructured":"Lorenzo, A., Razzaboni, B., Weir, G.C. & Yankner, B.A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368, 756\u2013760 (1994).","journal-title":"Nature"},{"key":"BFni1935_CR22","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","volume":"48","author":"J Janson","year":"1999","unstructured":"Janson, J., Ashley, R.H., Harrison, D., McIntyre, S. & Butler, P.C. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48, 491\u2013498 (1999).","journal-title":"Diabetes"},{"key":"BFni1935_CR23","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s00125-008-1255-x","volume":"52","author":"S Zraika","year":"2009","unstructured":"Zraika, S. et al. Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis. Diabetologia 52, 626\u2013635 (2009).","journal-title":"Diabetologia"},{"key":"BFni1935_CR24","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1007\/s00125-010-1671-6","volume":"53","author":"S Zraika","year":"2010","unstructured":"Zraika, S. et al. Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence? Diabetologia 53, 1046\u20131056 (2010).","journal-title":"Diabetologia"},{"key":"BFni1935_CR25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s004410050998","volume":"291","author":"MK Badman","year":"1998","unstructured":"Badman, M.K., Pryce, R.A., Charge, S.B., Morris, J.F. & Clark, A. Fibrillar islet amyloid polypeptide (amylin) is internalised by macrophages but resists proteolytic degradation. Cell Tissue Res. 291, 285\u2013294 (1998).","journal-title":"Cell Tissue Res."},{"key":"BFni1935_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3109\/13506129809007297","volume":"5","author":"EJ de Koning","year":"1998","unstructured":"de Koning, E.J. et al. Macrophages and pancreatic islet amyloidosis. Amyloid 5, 247\u2013254 (1998).","journal-title":"Amyloid"},{"key":"BFni1935_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000026432","volume":"7","author":"BD Gitter","year":"2000","unstructured":"Gitter, B.D., Cox, L.M., Carlson, C.D. & May, P.C. Human amylin stimulates inflammatory cytokine secretion from human glioma cells. Neuroimmunomodulation 7, 147\u2013152 (2000).","journal-title":"Neuroimmunomodulation"},{"key":"BFni1935_CR28","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1046\/j.1471-4159.2000.0741017.x","volume":"74","author":"SL Yates","year":"2000","unstructured":"Yates, S.L. et al. Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia. J. Neurochem. 74, 1017\u20131025 (2000).","journal-title":"J. Neurochem."},{"key":"BFni1935_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1083\/jcb.200903124","volume":"187","author":"M Lamkanfi","year":"2009","unstructured":"Lamkanfi, M. et al. Glyburide inhibits the Cryopyrin\/Nalp3 inflammasome. J. Cell Biol. 187, 61\u201370 (2009).","journal-title":"J. Cell Biol."},{"key":"BFni1935_CR30","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1073\/pnas.0804897106","volume":"106","author":"FA Sharp","year":"2009","unstructured":"Sharp, F.A. et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc. Natl. Acad. Sci. USA 106, 870\u2013875 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1935_CR31","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cell.2007.12.040","volume":"132","author":"M Keller","year":"2008","unstructured":"Keller, M., Ruegg, A., Werner, S. & Beer, H.D. Active caspase-1 is a regulator of unconventional protein secretion. Cell 132, 818\u2013831 (2008).","journal-title":"Cell"},{"key":"BFni1935_CR32","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1124\/mol.104.008615","volume":"67","author":"DL Hay","year":"2005","unstructured":"Hay, D.L., Christopoulos, G., Christopoulos, A., Poyner, D.R. & Sexton, P.M. Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes. Mol. Pharmacol. 67, 1655\u20131665 (2005).","journal-title":"Mol. Pharmacol."},{"key":"BFni1935_CR33","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle, A. et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-\u03b2. Nat. Immunol. 9, 857\u2013865 (2008).","journal-title":"Nat. Immunol."},{"key":"BFni1935_CR34","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1182\/blood.V90.8.2911","volume":"90","author":"Y Hamon","year":"1997","unstructured":"Hamon, Y. et al. Interleukin-1\u03b2 secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1. Blood 90, 2911\u20132915 (1997).","journal-title":"Blood"},{"key":"BFni1935_CR35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ni.1831","volume":"11","author":"R Zhou","year":"2010","unstructured":"Zhou, R., Tardivel, A., Thorens, B., Choi, I. & Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136\u2013140 (2010).","journal-title":"Nat. Immunol."},{"key":"BFni1935_CR36","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1210\/jc.2008-0396","volume":"93","author":"M Boni-Schnetzler","year":"2008","unstructured":"Boni-Schnetzler, M. et al. Increased interleukin (IL)-1\u03b2 messenger ribonucleic acid expression in beta-cells of individuals with type 2 diabetes and regulation of IL-1\u03b2 in human islets by glucose and autostimulation. J. Clin. Endocrinol. Metab. 93, 4065\u20134074 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFni1935_CR37","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1172\/JCI200215318","volume":"110","author":"K Maedler","year":"2002","unstructured":"Maedler, K. et al. Glucose-induced beta cell production of IL-1\u03b2 contributes to glucotoxicity in human pancreatic islets. J. Clin. Invest. 110, 851\u2013860 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFni1935_CR38","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.2337\/diabetes.54.11.3238","volume":"54","author":"N Welsh","year":"2005","unstructured":"Welsh, N. et al. Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets? Diabetes 54, 3238\u20133244 (2005).","journal-title":"Diabetes"},{"key":"BFni1935_CR39","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1074\/jbc.M209634200","volume":"278","author":"YI Miller","year":"2003","unstructured":"Miller, Y.I. et al. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4\/MD-2, and inhibits phagocytosis of apoptotic cells. J. Biol. Chem. 278, 1561\u20131568 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFni1935_CR40","first-page":"42","volume":"1","author":"E Apolinario","year":"2006","unstructured":"Apolinario, E. et al. Minimally modified (electronegative) LDL\u2013 and Anti-LDL\u2013 autoantibodies in diabetes mellitus and impaired glucose tolerance. Int. J Atheroscler. 1, 42\u201347 (2006).","journal-title":"Int. J Atheroscler."},{"key":"BFni1935_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cccn.2003.09.020","volume":"340","author":"M Yano","year":"2004","unstructured":"Yano, M. et al. Increased electronegative charge of serum low-density lipoprotein in patients with diabetes mellitus. Clin. Chim. Acta 340, 93\u201398 (2004).","journal-title":"Clin. Chim. Acta"},{"key":"BFni1935_CR42","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1007\/s00125-007-0642-z","volume":"50","author":"A Abderrahmani","year":"2007","unstructured":"Abderrahmani, A. et al. Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells. Diabetologia 50, 1304\u20131314 (2007).","journal-title":"Diabetologia"},{"key":"BFni1935_CR43","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4049\/jimmunol.0901363","volume":"183","author":"FG Bauernfeind","year":"2009","unstructured":"Bauernfeind, F.G. et al. Cutting edge: NF-\u03baB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183, 787\u2013791 (2009).","journal-title":"J. Immunol."},{"key":"BFni1935_CR44","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/ilar.47.3.225","volume":"47","author":"AV Matveyenko","year":"2006","unstructured":"Matveyenko, A.V. & Butler, P.C. Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes. ILAR J. 47, 225\u2013233 (2006).","journal-title":"ILAR J."},{"key":"BFni1935_CR45","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2337\/diabetes.52.2.372","volume":"52","author":"RL Hull","year":"2003","unstructured":"Hull, R.L. et al. Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes 52, 372\u2013379 (2003).","journal-title":"Diabetes"},{"key":"BFni1935_CR46","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.2337\/diabetes.52.9.2304","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler, A.E., Janson, J., Soeller, W.C. & Butler, P.C. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52, 2304\u20132314 (2003).","journal-title":"Diabetes"},{"key":"BFni1935_CR47","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1073\/pnas.0914795107","volume":"107","author":"FL van de Veerdonk","year":"2010","unstructured":"van de Veerdonk, F.L. et al. Reactive oxygen species-independent activation of the IL-1\u03b2 inflammasome in cells from patients with chronic granulomatous disease. Proc. Natl. Acad. Sci. USA 107, 3030\u20133033 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1935_CR48","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357\u20131361 (2010).","journal-title":"Nature"},{"key":"BFni1935_CR49","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1172\/JCI28898","volume":"116","author":"H Shi","year":"2006","unstructured":"Shi, H. et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015\u20133025 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFni1935_CR50","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/sj.bjp.0707226","volume":"151","author":"JC Russell","year":"2007","unstructured":"Russell, J.C. & Proctor, S.D. Increased insulin sensitivity and reduced micro and macro vascular disease induced by 2-deoxy-D-glucose during metabolic syndrome in obese JCR: LA-cp rats. Br. J. Pharmacol. 151, 216\u2013225 (2007).","journal-title":"Br. J. Pharmacol."},{"key":"BFni1935_CR51","doi-asserted-by":"crossref","unstructured":"Michalska, M., Wolf, G., Walther, R. & Newsholme, P. The effects of pharmacologic inhibition of NADPH oxidase or iNOS on pro-inflammatory cytokine, palmitic acid or H2O2 -induced mouse islet or clonal pancreatic beta cell dysfunction. Biosci. Rep., published online doi:10.1042\/BSR20090138 (23 February 2010).","DOI":"10.1042\/BSR20090138"},{"key":"BFni1935_CR52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ymeth.2004.03.012","volume":"34","author":"MR Nilsson","year":"2004","unstructured":"Nilsson, M.R. Techniques to study amyloid fibril formation in vitro. Methods 34, 151\u2013160 (2004).","journal-title":"Methods"},{"key":"BFni1935_CR53","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.2337\/diabetes.50.11.2514","volume":"50","author":"F Wang","year":"2001","unstructured":"Wang, F., Hull, R.L., Vidal, J., Cnop, M. & Kahn, S.E. Islet amyloid develops diffusely throughout the pancreas before becoming severe and replacing endocrine cells. Diabetes 50, 2514\u20132520 (2001).","journal-title":"Diabetes"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ni.1935.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni.1935","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni.1935.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:37:17Z","timestamp":1684438637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ni.1935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,12]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["BFni1935"],"URL":"https:\/\/doi.org\/10.1038\/ni.1935","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.5277957.6754058","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.5277957.5760054","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.5277957.5219056","asserted-by":"object"}]},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,12]]}}}